The role of Ischemia modified albumin in detecting diabetic nephropathy | ||||
| SVU-International Journal of Medical Sciences | ||||
| Article 37, Volume 6, Issue 1, January 2023, Page 359-367 PDF (234.39 K) | ||||
| Document Type: Original research articles | ||||
| DOI: 10.21608/svuijm.2022.165289.1419 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Asmaa Ali Mahmoud Ahmed   1; Eman Hassan Ali Salama2; Hassan Ahmed Hassanein Shehata1; Amal Khalifa Ahmed Noreldin1
| ||||
| 1Department of Internal Medicine, Faculty of Medicine, Sohag University, Sohag 82524 , Egypt. | ||||
| 2Department of Clinical Pathology, Faculty of Medicine, Sohag University, Sohag 82524,Egypt. | ||||
| Abstract | ||||
| Background: Ischemia-modified albumin (IMA) is considered a marker of oxidative stress and ischemia. Objectives: In this study, we aimed at establishing an association between IMA and diabetic nephropathy (DN) in type2 Diabetes mellitus (T2DM) patients. Patients and methods: One hundred individual participated in the study.70 T2DM patients, 35 in group A had DN, 35 in group B without DN and 30 healthy individuals, group C as a control group. We used urinary microalbuminuria test and urinary albumin creatinine ratio for assessment of diabetic nephropathy. Results: plasma levels of IMA were higher in T2DM with DN (122.47±7.23) u/ml than in T2DM without DN(79.60±7.76) u/mlwho were higher than the control group (41.79±1.54)u/ml, p 110.5 u/ml (sensitivity=100%, specificity=94.4%, PPV=87.9% NPP=100%). Conclusion: The ischemia modified albumin levels were significantly higher and positively associated with the duration of diabetes, RBS and HbA1c levels in T2DM patients with nephropathy. IMA could be used as a risk marker for Type 2 diabetic nephropathy. | ||||
| Keywords | ||||
| Ischemia modified albumin; Diabetes Mellitus; Random blood glucose; Diabetic nephropathy | ||||
|
Statistics Article View: 276 PDF Download: 371 |
||||
